Wirth A - Search Results

1

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.

Hertzberg M, Gandhi MK, Trotman J, Butcher B, Taper J, Johnston A, Gill D, Ho SJ, Cull G, Fay K, Chong G, Grigg A, Lewis ID, Milliken S, Renwick W, Hahn U, Filshie R, Kannourakis G, Watson AM, Warburton P, Wirth A, Seymour JF, Hofman MS, Hicks RJ; Australasian Leukaemia Lymphoma Group (ALLG). Hertzberg M, et al. Among authors: wirth a. Haematologica. 2017 Feb;102(2):356-363. doi: 10.3324/haematol.2016.154039. Epub 2016 Nov 10. Haematologica. 2017. PMID: 28143954 Free PMC article. Clinical Trial.

2

High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.

MacManus MP, Hicks RJ, Matthews JP, Hogg A, McKenzie AF, Wirth A, Ware RE, Ball DL. MacManus MP, et al. Among authors: wirth a. Int J Radiat Oncol Biol Phys. 2001 Jun 1;50(2):287-93. doi: 10.1016/s0360-3016(01)01477-8. Int J Radiat Oncol Biol Phys. 2001. PMID: 11380213 Clinical Trial.

3

High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experience.

Dowling AJ, Prince HM, Wirth A, Wolf M, Januszewicz EH, Juneja S, Seymour JF, Gates P, Smith JG. Dowling AJ, et al. Among authors: wirth a. Intern Med J. 2001 Jul;31(5):279-89. doi: 10.1046/j.1445-5994.2001.00066.x. Intern Med J. 2001. PMID: 11512599

4

F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment.

Mac Manus MP, Hicks RJ, Ball DL, Kalff V, Matthews JP, Salminen E, Khaw P, Wirth A, Rischin D, McKenzie A. Mac Manus MP, et al. Among authors: wirth a. Cancer. 2001 Aug 15;92(4):886-95. doi: 10.1002/1097-0142(20010815)92:4<886::aid-cncr1397>3.0.co;2-v. Cancer. 2001. PMID: 11550162

5

Successful transplant outcome in a morbidly obese patient with acute myeloblastic leukemia.

Ritchie DS, Wirth A, Grigg AP. Ritchie DS, et al. Among authors: wirth a. Leuk Lymphoma. 2001 Sep-Oct;42(5):1111-4. doi: 10.3109/10428190109097732. Leuk Lymphoma. 2001. PMID: 11697629

6

Primary large-cell non-Hodgkin's lymphoma of the testis: a retrospective analysis of patterns of failure and prognostic factors.

Seymour JF, Solomon B, Wolf MM, Janusczewicz EH, Wirth A, Prince HM. Seymour JF, et al. Among authors: wirth a. Clin Lymphoma. 2001 Sep;2(2):109-15. doi: 10.3816/clm.2001.n.016. Clin Lymphoma. 2001. PMID: 11707851

7

Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center.

Mac Manus MP, Wong K, Hicks RJ, Matthews JP, Wirth A, Ball DL. Mac Manus MP, et al. Among authors: wirth a. Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):351-61. doi: 10.1016/s0360-3016(01)02673-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 11872280

8

Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.

Wirth A, Seymour JF, Hicks RJ, Ware R, Fisher R, Prince M, MacManus MP, Ryan G, Januszewicz H, Wolf M. Wirth A, et al. Am J Med. 2002 Mar;112(4):262-8. doi: 10.1016/s0002-9343(01)01117-2. Am J Med. 2002. PMID: 11893364

9

Imaging with F-18 FDG PET is superior to Tl-201 SPECT in the staging of non-small cell lung cancer for radical radiation therapy.

MacManus MP, Hicks RJ, Ball DL, Ciavarella F, Binns D, Hogg A, Kalff V, Ware R, Wirth A, Salminen E, McKenzie A. MacManus MP, et al. Among authors: wirth a. Australas Radiol. 2001 Nov;45(4):483-90. doi: 10.1046/j.1440-1673.2001.00960.x. Australas Radiol. 2001. PMID: 11903182

10

FDG-PET-detected extracranial metastasis in patients with non-small cell lung cancer undergoing staging for surgery or radical radiotherapy--survival correlates with metastatic disease burden.

MacManus MR, Hicks R, Fisher R, Rischin D, Michael M, Wirth A, Ball DL. MacManus MR, et al. Among authors: wirth a. Acta Oncol. 2003;42(1):48-54. doi: 10.1080/0891060310002230. Acta Oncol. 2003. PMID: 12665331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

529 results

Search Page

Filters